CAD 0.11
(50.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2024 Q3 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q1 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | 100.0% |
CanadaBis Capital Inc. | 22.22 Million CAD | 100.0% |
Decibel Cannabis Company Inc. | 115.95 Million CAD | 100.0% |
Delivra Health Brands Inc. | 12.37 Million CAD | 100.0% |
Entourage Health Corp. | 40.71 Million CAD | 100.0% |
Lifeist Wellness Inc. | 21.65 Million CAD | 100.0% |
Cannara Biotech Inc. | 57.26 Million CAD | 100.0% |
Medicure Inc. | 21.69 Million CAD | 100.0% |
PharmaCielo Ltd. | 1.54 Million CAD | 100.0% |
Rubicon Organics Inc. | 40.11 Million CAD | 100.0% |
BioSyent Inc. | 31.59 Million CAD | 100.0% |